Boulegeris Investments’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Boulegeris Investments’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-8,151	Closed	-$372K	–	47
2016 Q1	$372K	Buy	8,151 +15	+0.2%	+$702	0.26%	39
2015 Q4	$439K	Buy	8,136 +105	+1%	+$5.52K	0.32%	37
2015 Q3	$396K	Buy	8,031 +1,650	+26%	+$94.6K	0.3%	37
2015 Q2	$372K	Buy	6,381 +12	+0.2%	+$701	0.27%	40
2015 Q1	$366K	Buy	6,369 +906	+17%	+$49.6K	0.27%	39
2014 Q4	$276K	Buy	5,463 +12	+0.2%	+$585	0.22%	39
2014 Q3	$255K	Buy	+5,451	New	+$246K	0.21%	42

Other funds holding IHE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AWA

ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Spinnaker Trust Portland, Maine $1.81B AUM 17.83% 1-Year Est. Return

SFI

SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

EAMA

EFG Asset Management (Americas) Miami, Florida $579M AUM 24.22% 1-Year Est. Return

Boulegeris Investments's IHE Position: Q2 2016 in Review

Boulegeris Investments sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2016, closing a stake of 8,151 shares — an estimated $372K sold.

Boulegeris Investments first reported a position in IHE in Q3 2014 and held it in 7 quarters. The position peaked at $439K in Q4 2015. 87 funds tracked by Wall St. Rank hold IHE as of Q2 2016.

Boulegeris Investments reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2016 after selling out during the quarter.
Boulegeris Investments sold 8,151 iShares US Pharmaceuticals ETF shares in Q2 2016, an estimated $372K.
Boulegeris Investments first reported a position in iShares US Pharmaceuticals ETF in Q3 2014 and held it in 7 quarters.
Boulegeris Investments's iShares US Pharmaceuticals ETF position peaked at $439K in Q4 2015.
87 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2016.

Based on Boulegeris Investments's 13F filing for Q2 2016, filed 12 Jul 2016.